FYI Resources Limited (FYI) is an ASX listed company headquartered in Perth, Western Australia.

Until recently, FYI Resources Limited was focused on the development of a novel glycoalkaloid mixture known as Coramsine (SBP002) extracted from the fruit of the plant Solannum linneanum, commonly known as 'The Devil's Apple' as a potential pharmaceutical compound and on the acquisition of health care assets in the Asia-Pacific region. In 2009, the Company out-licensed the Coramsine intellectual property platform technology.

In late 2009, the Company sought shareholder approval to change the Company's core business activity to that of mineral exploration. To that end FYI Resources Limited is currently completing a transaction that will involve the Company acquiring an exploration asset in Western Australia that is prospective for uranium.